Tech News Summary:
- The Sleip app uses AI to detect and diagnose lameness in horses through smartphone technology, providing veterinarians with objective and accurate assessment of equine health.
- A commercial partnership between Boehringer Ingelheim and Sleip aims to expand access to AI technology for the detection, diagnosis, and treatment of lameness in horses, ultimately improving equine welfare and veterinary practice.
- The collaboration between Boehringer Ingelheim and Sleip signifies a significant advancement in utilizing AI technology for equine healthcare, with plans to promote the Sleip app among veterinary clients and expand into key equine markets globally.
Boehringer Ingelheim, a leading provider of animal health products, has announced a collaboration with Sleip, a cutting-edge technology company, to revolutionize equine health using artificial intelligence (AI). The two companies have joined forces to develop a state-of-the-art AI system for the early detection of lameness in horses.
Lameness is a common issue among horses and can significantly impact their performance and overall well-being. Early detection is crucial in preventing long-term damage and ensuring appropriate treatment. With the help of AI technology, Boehringer Ingelheim and Sleip aim to provide horse owners, trainers, and veterinarians with a powerful tool for identifying lameness at its earliest stages.
Sleip specializes in AI-based motion analysis, and through this partnership, the company will leverage its expertise to develop a system that can accurately detect subtle changes in a horse’s movement indicative of lameness. By combining this advanced technology with Boehringer Ingelheim’s deep understanding of equine health and extensive network within the equestrian community, the collaboration is poised to make a significant impact on the industry.
Dr. Diana Lüttgen, Head of Global Marketing Livestock at Boehringer Ingelheim, expressed excitement about the collaboration, stating, “We are committed to advancing animal health through innovation, and our partnership with Sleip represents a major step forward in our efforts to improve equine health. By harnessing the power of AI, we hope to provide horse owners and veterinarians with a groundbreaking tool for the early detection and management of lameness.”
The AI system being developed by Boehringer Ingelheim and Sleip has the potential to transform the way lameness is diagnosed and treated in horses. By enabling early intervention, the technology could help prevent long-term damage and improve the overall welfare of horses across the globe.
As the project continues to progress, the collaboration between Boehringer Ingelheim and Sleip is poised to make a lasting impact on equine health, solidifying their positions as leaders in the advancement of animal health through innovative technologies.